Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

NewAmsterdam Pharma (NAMS) Return on Assets (2024 - 2025)

NewAmsterdam Pharma (NAMS) has disclosed Return on Assets for 2 consecutive years, with 0.26% as the latest value for Q4 2025.

  • Quarterly Return on Assets rose 11.0% to 0.26% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.26% through Dec 2025, up 11.0% year-over-year, with the annual reading at 0.25% for FY2025, 15.0% up from the prior year.
  • Return on Assets hit 0.26% in Q4 2025 for NewAmsterdam Pharma, up from 0.28% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.2% in Q2 2025 to a low of 0.55% in Q1 2024.